High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$551K
$551,059
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RNTX
P
Rein Therapeutics, Inc.
Voss Capital, LP
• 10% Owner
Discretionary BuyΔOwn +12.7%
2025-11-14
$127,593
|
||||||
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +12.7%
|
2025-11-14 | $127,593 | P | Form 4 |
|
RNTX
P
Rein Therapeutics, Inc.
Voss Capital, LP
• 10% Owner
Discretionary BuyΔOwn +55.5%
2025-10-28
$247,965
|
||||||
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +55.5%
|
2025-10-28 | $247,965 | P | Form 4 |
|
RNTX
P
Rein Therapeutics, Inc.
Voss Capital, LP
• 10% Owner
Discretionary BuyΔOwn +12.7%
2025-10-27
$133,544x2
|
||||||
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +12.7%
|
2025-10-27 | $133,544x2 | P | Form 4 |
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-24 | $41,957 | P | Form 4 |